Production of 5-Aza-TdC Capsules for Clinical Use

Irisys, Inc., San Diego CA

Investigators

Abstract

PRODUCTION OF TWO THOUSAND CAPSULES OF 4 MG AZA-TDCPOP: 03/04/19 THROUGH 03/03/20. The batch of product was produced by the contractor and sent to clinical repository. The shelf-life was also evaluated. The drug product will be used in the NCI clinical trials.